Is EC 608-209-4 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use EC 608-209-4? Is EC 608-209-4 safe for nursing mother and child? Does EC 608-209-4 extracts into breast milk? Does EC 608-209-4 has any long term or short term side effects on infants? Can EC 608-209-4 influence milk supply or can EC 608-209-4 decrease milk supply in lactating mothers?
Answer by DrLact: About EC 608-209-4 usage in lactation
No information is available on the clinical use of EC 608-209-4 during breastfeeding. Because EC 608-209-4 is 99.5% bound to plasma proteins, the amount in milk is likely to be low. However, its half-life is 25 to 48 hours and it might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during EC 608-209-4 therapy.
Alternate Drugs
Bevacizumab(Low Risk)
Thioguanine(Dangerous)
Gemcitabine(Dangerous)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Vincristine(Dangerous)
Letrozole(Dangerous)
Tamoxifen(Dangerous)
Erlotinib(Unsafe)
Trastuzumab(Unsafe)
Exemestane(Dangerous)
Mitoxantrone(Dangerous)
Cladribine(Dangerous)
Mercaptopurine(Safe)
Nivolumab(Unsafe)
Ipilimumab(Unsafe)
Hydroxyurea(Low Risk)
Vinblastine(Dangerous)
Cetuximab(Unsafe)
Etoposide(Dangerous)
Bleomycin(Dangerous)
Carboplatin(Dangerous)
Doxorubicin(Dangerous)
Vinorelbine(Dangerous)
Imatinib(Unsafe)
Paclitaxel(Dangerous)
Cyclophosphamide(Dangerous)
Dacarbazine(Dangerous)
Fluorouracil(Dangerous)
Cisplatin(Unsafe)
Azelaic Acid(Safe)
Dasatinib(Unsafe)
Alemtuzumab(Low Risk)
Dactinomycin(Dangerous)
Busulfan(Dangerous)
Docetaxel(Dangerous)
Rituximab(Low Risk)
Orlistat(Low Risk)
Gemcitabine(Dangerous)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Allopurinol(Safe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Nilotinib(Unsafe)